Market Performance
Beyond Air (ticker: XAIR) closed the trading day on Friday 23 November 2026 with a 6.85 % gain, reaching a price of approximately USD 2.30 on major exchanges. The stock was traded for USD 67.6 k during the preceding 24 hours, and the volume of shares available in the market is 986.3 k. The company’s market capitalization stands at USD 2.2 million.
In the month leading up to the end of October 2026, XAIR’s share price fell 26.88 %. Over the past 200 days, the simple moving average is USD 11.23. The 52‑week high was USD 53.20, recorded on 13 January 2026, while the 52‑week low was USD 2.05, recorded on 14 October 2026.
Comparative Stock Movements
| Company | Ticker | 24‑hour change | Current price | Market capitalization | P/E ratio |
|---|---|---|---|---|---|
| Im Cannabis | IMCC | -15 % | USD 0.92 | USD 2.3 million | – |
| Suny Cellular Communication | SNCM.TA | -1.05 % | ILA 141 | ILA 101.7 million | 7.5 |
| Glucotrack | GCTK | -1.84 % | USD 0.60 | USD 1.5 million | – |
| Abra Information Technologie | ABRA.TA | -1.19 % | ILA 357.3 | ILA 135.1 million | 31.29 |
| Prf | PRFX | +5.38 % | USD 0.72 | USD 2.5 million | – |
Company Overview
Beyond Air, Inc. is a medical device and biopharmaceutical firm headquartered in Rehovot, Israel. The company focuses on the discovery and development of nitric‑oxide‑based formulations and delivery systems intended to treat respiratory diseases. Beyond Air serves patients and customers in the United States and Israel, operates a corporate website at www.beyondair.net , and is listed on the Nasdaq stock exchange.